Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2493)
All Articles published online
|
Sep 21, 2006 (publication date) through Nov 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Feng H, Masaki T, Nonomura T, Morishita A, Jian G, Nakai S, Deguchi A, Uchida N, Himoto T, Iwama H, Usuki H, Wakabayashi H, Izuishi K, Yoshiji H, Kurokohchi K, Kuriyama S. Activation of c-Yes in hepatocellular carcinoma: A preliminary study. World J Gastroenterol 2006; 12(35): 5743-5745 [PMID: 17007035 DOI: 10.3748/wjg.v12.i35.5743] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i35/5743.htm |
| Number | Citing Articles |
| 1 |
c-Yes enhances tumor migration and invasion via PI3K/AKT pathway in epithelial ovarian cancer. Experimental and Molecular Pathology 2016; 101(1): 50 doi: 10.1016/j.yexmp.2016.06.002
|
| 2 |
Lóránd Váncza, Katalin Karászi, Bálint Péterfia, Lilla Turiák, Katalin Dezső, Anna Sebestyén, Andrea Reszegi, Gábor Petővári, András Kiss, Zsuzsanna Schaff, Kornélia Baghy, Ilona Kovalszky. SPOCK1 Promotes the Development of Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.819883
|
| 3 |
Irati Garmendia, Esther Redin, Luis M. Montuenga, Alfonso Calvo. YES1: A Novel Therapeutic Target and Biomarker in Cancer. Molecular Cancer Therapeutics 2022; 21(9): 1371 doi: 10.1158/1535-7163.MCT-21-0958
|
| 4 |
Jessica Jung, Sung Chul Choi, Han-Na Lee, Gi-Yeon Han, Chan-Wha Kim. Inhibition of c-Yes induces differentiation of HT-29 human colon cancer stem cells through midbody elongation. Tissue Engineering and Regenerative Medicine 2016; 13(3): 261 doi: 10.1007/s13770-016-9053-x
|
| 5 |
Esther Redin, Eva M. Garrido-Martin, Karmele Valencia, Miriam Redrado, Jose Luis Solorzano, Rafael Carias, Mirari Echepare, Francisco Exposito, Diego Serrano, Irene Ferrer, Angel Nunez-Buiza, Irati Garmendia, Juana M. García-Pedrero, Alfonso Gurpide, Luis Paz-Ares, Katerina Politi, Luis M. Montuenga, Alfonso Calvo. YES1 Is a Druggable Oncogenic Target in SCLC. Journal of Thoracic Oncology 2022; 17(12): 1387 doi: 10.1016/j.jtho.2022.08.002
|
| 6 |
Hai Zhou, Dantong Sun, Junyan Tao, Mingjin Xu, Xiaochun Zhang, Helei Hou. Role of YES1 signaling in tumor therapy resistance. Cancer Innovation 2023; 2(3): 210 doi: 10.1002/cai2.51
|